Patents Assigned to Humanwell Pharmaceutical US
  • Peptides for treatment of medical disorders
    Patent number: 11492374
    Abstract: The present invention provides compounds which are selective kappa-opioid receptor agonist, method of preparation of these compounds, compositions that comprise these compounds, and methods for treating kappa-opiod receptor agonist related medical disorders.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: November 8, 2022
    Assignee: Humanwell Pharmaceutical US
    Inventors: Subo Liao, Jun Yang, Jinliang Lv, Zongquan Liao, Hao Zhou, Jueyuan Gao, Tianpeng Xie, Quanli Yang
  • Morphinans useful for treating medical disorders
    Patent number: 11214577
    Abstract: The present invention related to novel morphinans, compositions comprising the novel morphinans, and their uses as agonists of the kappa opioid receptor.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: January 4, 2022
    Assignee: Humanwell Pharmaceutical US
    Inventors: Subo Liao, Jun Yang, Jie Li, Wentao Du, Lie Li, Jinliang Lv, Zongquan Liao, Hao Zhou, Tianpeng Xie, Jianbo Yu
  • Solid Dosage Forms
    Publication number: 20190054024
    Abstract: A solid pharmaceutical dosage form having drug-loaded particles and methods of making.
    Type: Application
    Filed: August 16, 2017
    Publication date: February 21, 2019
    Applicants: HUMANWELL PHARMACEUTICAL US, Inc., YICHANG HUMANWELL PHARMACEUTICAL CO., LTD.
    Inventors: Jun Yang, Yunqi Wu, Dunxi Chen, Cuiying Zhang, Yuping Yang, Longmei Qu, Lie Li, Jie Li, Wentao Du, Yigang Fu